RBM Insider Trading Activity and SEC Form 4 Filings
RBM insider trading summary
No open-market insider purchases or sales of Response Biomedical Corp (RBM) have been reported on SEC Form 4 in the past 12 months.
Latest RBM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 16, 2016 | Orbimed Advisors LLC | Director | Buy | $312K (556,339 @ $0.56) |
| Jun 16, 2016 | OrbiMed Capital GP III LLC | Director | Buy | $312K (556,339 @ $0.56) |
| Jun 16, 2016 | Samuel D Isaly | Director | Buy | $312K (556,339 @ $0.56) |
| Jun 16, 2016 | Orbimed Asia Gp, LP | Director | Buy | $312K (556,339 @ $0.56) |
| Jun 16, 2016 | Orbimed Advisors LLC | Director | Buy | $3K (5,294 @ $0.56) |
| Jun 16, 2016 | OrbiMed Advisors Ltd | Director | Buy | $312K (556,339 @ $0.56) |
| Jun 16, 2016 | Samuel D Isaly | Director | Buy | $3K (5,294 @ $0.56) |
| Jun 16, 2016 | OrbiMed Capital GP III LLC | Director | Buy | $3K (5,294 @ $0.56) |
| Jun 16, 2016 | OrbiMed Advisors Ltd | Director | Buy | $3K (5,294 @ $0.56) |
| Jun 16, 2016 | Orbimed Asia Gp, LP | Director | Buy | $3K (5,294 @ $0.56) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.